1. Brentuximab vedotin: A retrospective multicenter analysis of its indication, safety and efficacy in Argentina. (June 2017) Authors: Negri Aranguren, M.F.; Shanley, C.; Cranco, S.; Otero, V.; Fiad, L.; Fernandez, I.; Miodosky, M.; Kusminsky, G.; Corso, A.; Bistmans, A.; Huber, M.; Marull, M.; Jarchum, S.; Guanchiale, L.; Marquez, M.; Beligoy, L.; Cerutti, I.; Navieckas, A.; Tamashiro, M.; Pujol, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of Ligands of the Activating Receptor NKG2D in Myelodysplastic Syndrome and Acute Myelogenous Leukemia Blasts and Lymphoid Cells. (April 2017) Authors: Secchiari, F.; Iastrebner, M.; Nuñez, S.Y.; Tamashiro, M.; Torres, N.I.; Sierra, J.M.; Ziblat, A.; Fuertes, M.B.; Domaica, C.I.; Zwirner, N.W. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗